Blood Transfusion Risk Factors and Cell Saver Impact in Pediatric Scoliosis Surgery
Risk Factors for Homologous Blood Transfusion and Impact of Cell Saver Use in Pediatric Scoliosis Surgery: A Retrospective Monocentric Study
Mehdi Trifa
200 participants
Apr 1, 2023
OBSERVATIONAL
Conditions
Summary
Spine surgery for scoliosis correction in pediatric patients is a major procedure associated with a high risk of perioperative blood loss. Homologous blood transfusion carries inherent risks, including immunological reactions, infections, and increased healthcare costs. Identifying high-risk patients is crucial to optimize blood conservation strategies. This retrospective study aims to identify preoperative and intraoperative risk factors associated with homologous red blood cell (RBC) transfusion and to evaluate the quantitative impact of Cell Saver volume reinfusion on reducing homologous transfusion requirements.
Eligibility
Inclusion Criteria3
- Patient aged under 18 years (< 18 years old).
- Programmed surgical correction for scoliosis (including idiopathic, neuromuscular, and congenital etiologies).
- Instrumented surgery involving posterior spinal arthrodesis.
Exclusion Criteria4
- Revision spine surgeries.
- Known constitutional hemostasis disorders.
- Non-orthopedic spine surgeries.
- Missing core clinical or transfusion data.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Standard surgical correction of scoliosis via a posterior approach with spinal instrumentation and arthrodesis, performed under general anesthesia
Use of an intraoperative autologous blood salvage device (Cell Saver) during spine surgery. Collected blood is washed, filtered, and reinfused to the patient peroperatively to reduce the need for homologous blood transfusion.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07661589